From December 31, 2023 to March 30, 2024, the company has repurchased 194,000 shares, representing 1.01% for $9 million. With this, the company has completed the repurchase of 7,617,925 shares, representing 34.21% for $650.74 million under the buyback announced on December 8, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.57 USD | +0.13% |
|
+1.36% | -14.98% |
07/05 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
01/05 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.98% | 867M | |
+13.80% | 8.09B | |
+0.47% | 7.39B | |
-8.08% | 5.37B | |
-6.72% | 3.63B | |
-19.73% | 3.27B | |
-12.00% | 1.19B | |
-26.74% | 1.13B | |
+0.89% | 879M | |
-12.89% | 846M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015.